NORTHBROOK, Ill., Aug. 5, 2019 /PRNewswire/ -- The Children's Heart Foundation, the nation's leading organization dedicated to funding congenital hear

DAVIS, Calif., Aug. 5, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops

AUSTIN, Texas, Aug. 5, 2019 /PRNewswire/ -- Epiphany Dermatology, a leading dermatology company committed to improving access to exceptional dermatologic care, announced today it has expanded its presence in Arizona through its partnership with Cochise Dermatology.  Founded in 1996 by Angelo Petropolis, MD, Cochise

BOSTON, Aug. 5, 2019 /PRNewswire/ -- Bend Financial (Bend), today announced the signing of a long-term agreement with Elements Financial Federal Credit Union to provide the health savings account (HSA) technology solution for their more than 15,000 accountholders and 80 employers. The partnership positions Bend for strong growth and highlights the relevance of their diff

NEW YORK, Aug. 5, 2019 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Heron Therapeutics, Inc. ("Heron" or the "Company") (NASDAQ: HRTX) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Heron securities b

PHOENIX, Aug. 5, 2019 /PRNewswire/ -- Hyundai Hope On Wheels® (HHOW), a 501(c)(3) non-profit organization supported by Hyundai and its U.S.

BLAIRSVILLE, Pa., Aug. 5, 2019 /PRNewswire/ -- PHOENIX Rehabilitation and Health Services, Inc. ("PHOENIX"), an industry leader in the physical rehabilitation fie

PHILADELPHIA, Aug. 5, 2019 /PRNewswire/ -- Children's veins are small and sometimes difficult to access during necessary medical treatment. When caregivers used ultrasound to guide placement of intravenous (IV) lines in children with presumed difficult access, they had higher success rates on their first attempt. Researchers from Children's Hospital of

ROCKVILLE, Md., Aug. 5, 2019 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today confirmed that the first patient enrolled in a single-blinded, phase 2 clinical trial in patients with epidermolysis bullosa (EB)

PRINCETON, N.J., Aug 5, 2019 /PRNewswire/ -- Lenus Therapeutics, LLC (the 'Company'), a US-based joint venture between GtreeBNT ('Gtree') and Yuyang DNU ('Yuyang') in Korea, announced that it has confirmed complete wound healing of the index lesion of the first subject enrolled in its ongoing single-masked Phase 2 clinical trial with RGN-137 dermal gel for Ep